Résultats de la recherche - 18 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
Burden and Impact Studies (VEBIS) project. A retrospective cohort was constructed from linked electronic health records (EHR) in each country. Countryspecific (level) relative VE (rVE) was estimated on ...
Epidemiology of COVID-19 mortality in Belgium from wave 1 to wave 7 (March 2020 – 11 September 2022)
inhabitants), followed by Brussels-Capital Region (297 per 100,000 inhabitants) and Flanders (252 per 100,000 inhabitants). At provincial level (and Brussels-Capital Region), Hainaut had the highest overall ...
EBoD-FL. Guidelines for mapping the environmental burden of disease in Flanders
Environmental burden of disease (EBD) studies try to estimate the impact of environmental stressors in terms of mortality or morbidity on a population level. Although environmental risks have been studied in ...
Monitoring HIV pre-exposure prophylaxis programmes in the EU/EEA
addition, based on the input of the expert panel, all indicators are assigned a specific level of priority for reporting: ‘core indicators’ (i.e. essential indicators that should be feasible to report on); ...
Annual Report Belgian Cystic Fibrosis Registry 2018
xylosoxidans from 5.9% in 2009, stabilizing at prevalence levels of about 10.0% since 2012. The prevalence of the Burkholderia cepacia complex on the other hand has decreased to 3.0% in 2018, after a stable ...
Annual Report Belgian Cystic Fibrosis Registry 2017
levels above 10.0% since 2012, but reaching 11.4% in 2017. The prevalence of the Burkholderia cepacia complex on the other hand has decreased to 2.9%, after a stable period at 3.5% over the years since ...
Point Prevalence Study of Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute-Care Hospitals: Results of the ECDC PPS 2017
participate. Training was provided to the participating hospitals in September 2017, followed by the data collection between September and November 2017. Data were collected at hospital, ward and patient levels ...
Annual report Belgian Cystic Fibrosis Registry 2016
been a steady 14 Summ ar y increase in the prevalence of Achromobacter xylosoxidans from 5.9% in 2009 stabilizing at prevalence levels above 10.0% since 2012. Thanks to improved disease management ...
Initiative for Quality Improvement and Epidemiology in Multidisciplinary Diabetic Foot Clinics (IQED-Foot)- Results of the 4th data collection (audit years 2013-2014)
deserves further attention. Prospective follow-up data over 1 year (instead of 6 months) may be needed to adequately study outcomes of active Charcot foot. Analyses at the level of individual audits and ...
Programme de surveillance des septicémies à l'hôpital en Belgique- Rapport annuel 2013, Données 2000- 2013
interpretation of the annual trends at the national level. A pathogen was isolated in 85% of the BSI episodes, and the proportion of skin contaminants decreased from 2000 to 2013. The specific incidence of BSI ...